Robert Bradway, Amgen CEO (Reuters/Stephen Lam)
May 17, 2023 11:57 AM EDT
Deals
Law

Am­gen's CEO says he's 'con­fi­den­t' their $28B deal with Hori­zon can close de­spite FTC law­suit

Drew Armstrong

Executive Editor

A day af­ter fed­er­al an­titrust au­thor­i­ties sued to stop Am­gen’s $28 bil­lion takeover of Hori­zon Ther­a­peu­tics, Am­gen’s CEO said he still ex­pects the deal …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: Sage re­ports Phase 2 fail­ure in Hunt­ing­ton's dis­ease, ends drug's de­vel­op­ment

Car­olyn Bertozzi’s lat­est biotech de­buts with $30M seed round and a sug­ary spin on im­munother­a­py

Pfiz­er taps on­col­o­gy head Boshoff as Dol­sten's chief sci­en­tif­ic of­fi­cer suc­ces­sor

Pfiz­er part­ners with two more Flag­ship biotechs on obe­si­ty, can­cer

Ex­clu­sive: For­mer Pfiz­er com­mer­cial chief An­gela Hwang to join Flag­ship

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times